Close

Sign in
Sign up

Menu

Intel
Data search
Signals
Startup Concierge
Get intel

Home
News
Synthace in a $25.6M deal backed by Horizon Ventures.

Synthace in a $25.6M deal backed by Horizon Ventures.

Biotech Health services Software Services

United Kingdom

Hong Kong

United States

Investments

19 December 2018

Share:

Synthace (company)

United Kingdom

Biotech Health services Software Services

Total investments received (USD): 70.31m

Round value (USD): 25.6m

Round investors: Horizons Ventures John Taysom Luminous VC SOSV

Company: Synthace

Industry: Biotech Health services Software Services

Related deals

Quell Therapeutics raises £35 million Series A financing round led by Syncona.

Biotech Health services Manufacturing

United Kingdom

Investments 10 May 2019

Exiscientia secures $26 million

Biotech Health services Pharma Software Services

United Kingdom

Germany

China

Investments 05 January 2019

Sidebar

Verticals

Financial Services
Food Industry
Education
E-commerce
Health services
Marketplace

Benelux

Belgium
Netherlands

DACH

Austria
Germany
Switzerland

Nordics and Baltics

Denmark
Estonia
Finland
Iceland
Latvia
Lithuania
Norway
Sweden

Western Europe

France
Ireland
Italy
Portugal
Spain
United Kingdom

About
Contact
Terms of service
Privacy policy

© All rights reserved Nordic 9 2016-2026. Made with in Stockholm

Top